These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24640637)

  • 1. The critical path from pump to pancreas: the impact of FDA regulation on the development of a closed-loop diabetes management system.
    Sanchez RM
    Food Drug Law J; 2013; 68(1):53-76, i. PubMed ID: 24640637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive insulin therapy in patients with type 1 diabetes mellitus.
    Switzer SM; Moser EG; Rockler BE; Garg SK
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):89-104. PubMed ID: 22575408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of the FDA and Regulatory Approval of New Devices for Diabetes Care.
    Jazowski SA; Winn AN
    Curr Diab Rep; 2017 Jun; 17(6):40. PubMed ID: 28439847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Setting Expectations for Successful Artificial Pancreas/Hybrid Closed Loop/Automated Insulin Delivery Adoption.
    Lewis D
    J Diabetes Sci Technol; 2018 Mar; 12(2):533-534. PubMed ID: 28918653
    [No Abstract]   [Full Text] [Related]  

  • 9. Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery.
    Klonoff DC
    Pediatr Endocrinol Rev; 2003 Dec; 1(2):94-100. PubMed ID: 16437014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging diabetes therapies and technologies.
    Moser EG; Morris AA; Garg SK
    Diabetes Res Clin Pract; 2012 Jul; 97(1):16-26. PubMed ID: 22381908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety auxiliary feedback element for the artificial pancreas in type 1 diabetes.
    Revert A; Garelli F; Pico J; De Battista H; Rossetti P; Vehi J; Bondia J
    IEEE Trans Biomed Eng; 2013 Aug; 60(8):2113-22. PubMed ID: 23428611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closed-loop in children with type 1 diabetes: specific challenges.
    Elleri D; Allen JM; Dunger DB; Hovorkea R
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S131-5. PubMed ID: 21864745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical review and analysis of ethical issues associated with the artificial pancreas.
    Quintal A; Messier V; Rabasa-Lhoret R; Racine E
    Diabetes Metab; 2019 Jan; 45(1):1-10. PubMed ID: 29753624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closing the loop.
    Dassau E; Atlas E; Phillip M
    Int J Clin Pract Suppl; 2011 Feb; (170):20-5. PubMed ID: 21323809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA & digital mammography: why has FDA required full field digital mammography systems to be regulated as potentially dangerous devices for more than 10 years?
    Nields MW
    Acad Radiol; 2010 May; 17(5):652-7. PubMed ID: 20380981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of insulin-dependent diabetes: new therapy by electromagnetic replacement: towards an artificial pancreas].
    Bringer J; Costalat G; Jaffiol C; Renard E
    Bull Acad Natl Med; 2003; 187(7):1285-94; discussion 1295. PubMed ID: 15146604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Artificial Pancreas: What School Nurses Need to Know.
    Latham J
    NASN Sch Nurse; 2019 Mar; 34(2):86-89. PubMed ID: 30382764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of reinforcement learning algorithms to meet the challenges of an artificial pancreas.
    Bothe MK; Dickens L; Reichel K; Tellmann A; Ellger B; Westphal M; Faisal AA
    Expert Rev Med Devices; 2013 Sep; 10(5):661-73. PubMed ID: 23972072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bringing the artificial pancreas home: telemedicine aspects.
    Lanzola G; Capozzi D; Serina N; Magni L; Bellazzi R
    J Diabetes Sci Technol; 2011 Nov; 5(6):1381-6. PubMed ID: 22226255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of automating insulin delivery for the treatment of type 1 diabetes.
    Steil GM; Rebrin K; Darwin C; Hariri F; Saad MF
    Diabetes; 2006 Dec; 55(12):3344-50. PubMed ID: 17130478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.